Black Diamond Therapeutics (BDTX) Ownership - Who Owns Black Diamond Therapeutics?

1,638 Followers

Black Diamond Therapeutics (BDTX) Ownership Overview

8.93% Insiders

16.84% Mutual Funds

34.13% Other Institutional Investors

7.41% ETFs

32.70% Public Companies and

Individual Investors

The ownership structure of Black Diamond Therapeutics (BDTX) stock is a mix of institutional, retail, and individual investors. Approximately 58.38% of the company’s stock is owned by Institutional Investors, 8.93% is owned by Insiders, and 32.70% is owned by Public Companies and Individual Investors.

The ownership structure of Black Diamond Therapeutics (BDTX) stock is a mix of institutional, retail, and individual investors. Approximately 50.97% of the company’s stock is owned by Institutional Investors, 8.93% is owned by Insiders, and 7.41% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2023	Graham Capital Management, L.p.	xxxxxxxxxxxxx	$364015
Dec 31, 2023	Royce & Associates Llc	xxxxxxxxxxxxx	$35850

Show More Hedge Fund Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
4,542,325	Insider	7.93%	7,949,069
2,646,444	Institution	4.62%	4,631,277
2,130,050	Institution	3.72%	3,727,588
1,792,699	Institution	3.13%	3,137,223
1,792,699	Institution	3.13%	3,137,223
1,396,549	Institution	2.44%	2,443,961
763,946	Institution	1.33%	1,336,906
636,362	Institution	1.11%	1,113,634
511,175	Institution	0.89%	894,556
483,000	Institution	0.84%	845,250

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
2,646,444	Institution	4.62%	4,631,277
2,130,050	Institution	3.72%	3,727,588
1,792,699	Institution	3.13%	3,137,223
1,396,549	Institution	2.44%	2,443,961
483,000	Institution	0.84%	845,250
467,750	Institution	0.82%	818,563
413,342	Institution	0.72%	723,349
152,352	Institution	0.27%	266,616
41,761	Institution	0.07%	73,082
30,769	Institution	0.05%	53,846

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	1,297,051	Institution	2.26%	3,437,185
Fidelity Enhanced Small Cap ETF	511,175	Institution	0.89%	930,339
Vanguard Extended Market ETF	495,648	Institution	0.86%	1,313,467
iShares Biotechnology ETF	341,308	Institution	0.60%	597,289
EA Bridgeway Omni Small-Cap Value ETF	246,951	Institution	0.43%	449,451
iShares MSCI USA Small-Cap Multifactor ETF	227,831	Institution	0.40%	398,704
Dimensional US Small Cap Value ETF	210,208	Institution	0.37%	367,864
Dimensional U.S. Small Cap ETF	190,895	Institution	0.33%	347,429
iShares Micro-Cap ETF	118,507	Institution	0.21%	207,387
Invesco FTSE RAFI US 1500 Small-Mid ETF	95,283	Institution	0.17%	173,415

FAQ

Who Owns Black Diamond Therapeutics, Inc. (BDTX)?

According to the latest TipRanks data, approximately 34.13% of the company's stock is held by institutional investors, 8.93% is held by insiders, and 32.70% is held by retail investors.

What percentage of Black Diamond Therapeutics, Inc. (BDTX) stock is held by institutional investors?

According to the latest TipRanks data, approximately 34.13% of Black Diamond Therapeutics, Inc. (BDTX) stock is held by institutional investors.

What percentage of Black Diamond Therapeutics, Inc. (BDTX) stock is held by retail investors?

According to the latest TipRanks data, approximately 32.70% of Black Diamond Therapeutics, Inc. (BDTX) stock is held by retail investors.

Who owns the most shares of Black Diamond Therapeutics, Inc. (BDTX)?

Ali Behbahani owns the most shares of Black Diamond Therapeutics, Inc. (BDTX).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.